BAROPHARM Co., Ltd. (KOSDAQ:0153R0)
6,700.00
-610.00 (-8.34%)
At close: Nov 17, 2026
BAROPHARM Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Operating Revenue | 145,030 | 96,724 | 45,538 | 11,591 |
Other Revenue | 0 | - | -0 | -0 |
| 145,030 | 96,724 | 45,538 | 11,591 | |
Revenue Growth | - | 112.40% | 292.88% | - |
Cost of Revenue | 119,653 | 81,151 | 34,374 | 4,668 |
Gross Profit | 25,377 | 15,573 | 11,164 | 6,923 |
Selling, General & Admin | 20,971 | 18,492 | 15,793 | 8,920 |
Amortization of Goodwill & Intangibles | 51.47 | 39.96 | 28.45 | 30.27 |
Other Operating Expenses | 292.5 | 190.42 | 168.3 | 129.3 |
Operating Expenses | 22,113 | 19,505 | 16,615 | 9,422 |
Operating Income | 3,263 | -3,932 | -5,451 | -2,499 |
Interest Expense | -483.12 | -73.81 | -58.76 | -91.63 |
Interest & Investment Income | 566.41 | 541.29 | 561.58 | 423.19 |
Other Non Operating Income (Expenses) | -1,757 | -6,211 | -12,426 | -4,939 |
EBT Excluding Unusual Items | 1,589 | -9,675 | -17,374 | -7,107 |
Gain (Loss) on Sale of Assets | 13.11 | 21.91 | -1.55 | - |
Pretax Income | 1,602 | -9,653 | -17,376 | -7,107 |
Income Tax Expense | 98.86 | 25.98 | 145.92 | - |
Net Income | 1,504 | -9,679 | -17,522 | -7,107 |
Net Income to Common | 1,504 | -9,679 | -17,522 | -7,107 |
Net Income Growth | - | - | - | - |
Shares Outstanding (Basic) | 9 | 7 | 6 | 6 |
Shares Outstanding (Diluted) | 9 | 7 | 6 | 6 |
Shares Change | - | 6.02% | 0.31% | - |
EPS (Basic) | 161.70 | -1461.38 | -2804.61 | -1141.00 |
EPS (Diluted) | 159.45 | -1461.38 | -2804.61 | -1141.00 |
EPS Growth | - | - | - | - |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Free Cash Flow | -19,193 | -26,127 | -2,560 | -5,902 |
Free Cash Flow Per Share | -2035.36 | -3944.59 | -409.69 | -947.69 |
Gross Margin | 17.50% | 16.10% | 24.52% | 59.73% |
Operating Margin | 2.25% | -4.06% | -11.97% | -21.56% |
Profit Margin | 1.04% | -10.01% | -38.48% | -61.31% |
Free Cash Flow Margin | -13.23% | -27.01% | -5.62% | -50.92% |
EBITDA | 4,179 | -3,088 | -4,798 | -2,126 |
EBITDA Margin | 2.88% | -3.19% | -10.54% | -18.34% |
D&A For EBITDA | 915.89 | 843.38 | 652.96 | 373.05 |
EBIT | 3,263 | -3,932 | -5,451 | -2,499 |
EBIT Margin | 2.25% | -4.06% | -11.97% | -21.56% |
Advertising Expenses | - | 2,397 | 1,204 | 932.01 |